{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:23:01Z","timestamp":1769599381453,"version":"3.49.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jogc.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Obstetrics and Gynaecology Canada"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jogc.2018.11.030","type":"journal-article","created":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T18:26:07Z","timestamp":1547144767000},"page":"e7-e17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["No. 313-Menstrual Suppression in Special Circumstances"],"prefix":"10.1016","volume":"41","author":[{"given":"Yolanda A.","family":"Kirkham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie P.","family":"Ornstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjali","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"McQuillan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogc.2018.11.030_bib0001","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1097\/AOG.0b013e3181c6f922","article-title":"ACOG Committee Opinion No. 448: Menstrual manipulation for adolescents with disabilities","volume":"114","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"7 Suppl 2","key":"10.1016\/j.jogc.2018.11.030_bib0002","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1701-2163(16)32526-9","article-title":"Society of Obstetricians and Gynaecologists of Canada. Canadian consensus guideline on continuous and extended hormonal contraception. SOGC Clinical Practice Guidelines, No. 195, July 2007","volume":"29","author":"Guilbert","year":"2007","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2018.11.030_bib0003","first-page":"707","article-title":"Society of Obstetricians and Gynecologists of Canada. Gynaecological and obstetric management of women with inherited bleeding disorders. SOGC Clinical Practice Guidelines, No. 163, July 2005","volume":"27","author":"Demers","year":"2005","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2018.11.030_bib0004","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jpag.2005.03.002","article-title":"Menstrual and contraceptive issues among young women with developmental delay: a retrospective review of cases at the Hospital for Sick Children, Toronto","volume":"18","author":"Dizon","year":"2005","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.jogc.2018.11.030_bib0005","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/adc.2009.174680","article-title":"The impact of menstruation in adolescents with disabilities related to cerebal palsy","volume":"95","author":"Zacharin","year":"2009","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jogc.2018.11.030_bib0006","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jpag.2009.04.005","article-title":"Gynecologic issues of adolescents with Down syndrome, autism, and cerebral palsy","volume":"23","author":"Burke","year":"2010","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.jogc.2018.11.030_bib0007","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/adc.2007.115709","article-title":"Suppression of menstruation in adolescents with severe learning disabilities","volume":"92","author":"Albanese","year":"2007","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jogc.2018.11.030_bib0008","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jadohealth.2013.04.014","article-title":"Trends in menstrual concerns and suppression in adolescents with developmental disabilities","volume":"53","author":"Kirkham","year":"2013","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.jogc.2018.11.030_bib0009","doi-asserted-by":"crossref","first-page":"108","DOI":"10.5694\/j.1326-5377.2002.tb04315.x","article-title":"Menstrual and contraceptive management in women with an intellectual disability","volume":"176","author":"Grover","year":"2002","journal-title":"Med J Aust"},{"key":"10.1016\/j.jogc.2018.11.030_bib0010","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1083-3188(03)00125-6","article-title":"Management of menstrual problems and contraception in adolescents with mental retardation: a medical, legal, and ethical review with new suggested guidelines","volume":"16","author":"Paransky","year":"2003","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.jogc.2018.11.030_bib0011","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/01.AOG.0000160430.61799.f6","article-title":"Extended use of transdermal norelgestromin\/EE: a randomized trial","volume":"105","author":"Stewart","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2018.11.030_bib0012","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/01.AOG.0000175144.08035.74","article-title":"Extended regimens of the contraceptive vaginal ring: a randomized trial","volume":"106","author":"Miller","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2018.11.030_bib0013","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0010-7824(87)90022-9","article-title":"Postponement of withdrawal bleeding in women using low-dose combined oral contraceptives","volume":"35","author":"Hamerlynck","year":"1987","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2018.11.030_bib0014","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/humrep\/dei377","article-title":"Continuous versus cyclic use of combined oral contraceptives for contraception: systematic Cochrane review of randomized controlled trials","volume":"21","author":"Edelman","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jogc.2018.11.030_bib0015","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.contraception.2009.05.128","article-title":"Continuous, daily levonorgestrel\/ethinyl estradiol vs. 21-day, cyclic levonorgestrel\/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trial","volume":"80","author":"Teichmann","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2018.11.030_bib0016","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/GCO.0b013e32832e493e","article-title":"Extended cycling or continuous use of hormonal contraceptives for female adolescents","volume":"21","author":"Gold","year":"2009","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.jogc.2018.11.030_bib0017","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.contraception.2010.06.013","article-title":"The use of hormonal contraception among women taking anticonvulsant therapy","volume":"83","author":"Gaffield","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2018.11.030_bib0018","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jpag.2007.10.008","article-title":"Menstrual suppression for adolescents with developmental disabilities","volume":"22","author":"Savasi","year":"2009","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.jogc.2018.11.030_bib0019","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jadohealth.2004.07.005","article-title":"Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls","volume":"35","author":"Cromer","year":"2004","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.jogc.2018.11.030_bib0020","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1054-139X(03)00367-7","article-title":"An evaluation of the use of the transdermal contraceptive patch in adolescents","volume":"34","author":"Rubinstein","year":"2004","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.jogc.2018.11.030_bib0021","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jpag.2004.11.016","article-title":"Adolescents\u2019 experience with the combined estrogen and progestin transdermal contraceptive method Ortho Evra","volume":"18","author":"Harel","year":"2005","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"2 Suppl 2","key":"10.1016\/j.jogc.2018.11.030_bib0022","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0015-0282(01)03275-7","article-title":"Contraceptive efficacy and cycle control with the Ortho Evra\/Evra transdermal system: the analysis of pooled data","volume":"77","author":"Zieman","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogc.2018.11.030_bib0023","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/AOG.0b013e3181842071","article-title":"Frequency and management of breakthrough bleeding with continuous use of the transvaginal contraceptive ring: a randomized controlled trial","volume":"112","author":"Sulak","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2018.11.030_bib0024","first-page":"219","article-title":"Canadian contraception consensus. SOGC Clinical Practice Guidelines, No. 143: Part 2 of 3","volume":"26","author":"Black","year":"2004","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2018.11.030_bib0025","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1196\/annals.1429.020","article-title":"Menstrual issues in adolescents with physical and developmental disabilities","volume":"1135","author":"Quint","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jogc.2018.11.030_bib0026","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00023210-200216040-00005","article-title":"Interactions between antiepileptic drugs and hormonal contraception","volume":"16","author":"Crawford","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jogc.2018.11.030_bib0027","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1701-2163(16)32125-9","article-title":"Ad Hoc DMPA Committee of the Society of Obstetricians and Gynaecologists of Canada. Canadian Contraception Consensus\u2014 Update on Depot Medroxyprogesterone Acetate (DMPA). SOGC Clinical Practice Guidelines, No. 174, April 2006","volume":"28","author":"Black","year":"2006","journal-title":"J Obstet Gynaecol Can"},{"issue":"6 Suppl 3","key":"10.1016\/j.jogc.2018.11.030_bib0028","first-page":"S37","article-title":"Antiepileptic drugs and hormonal contraceptives in adolescent women with epilepsy","volume":"66","author":"Zupanc","year":"2006","journal-title":"Neurol"},{"key":"10.1016\/j.jogc.2018.11.030_bib0029","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0010-7824(97)00156-X","article-title":"Effect of Depo-Provera or Microgynon on the painful crises of sickle cell anemia patients","volume":"56","author":"de Abood","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2018.11.030_bib0030","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/archpedi.159.2.139","article-title":"Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception","volume":"159","author":"Scholes","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.jogc.2018.11.030_bib0031","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.contraception.2007.10.005","article-title":"Bone density recovery after depot medroxyprogesterone acetate injectable contraception","volume":"77","author":"Kaunitz","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2018.11.030_bib0032","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.contraception.2009.11.003","article-title":"Recovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injections","volume":"81","author":"Harel","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2018.11.030_bib0033","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11154-011-9180-6","article-title":"Update on hormonal contraception and bone density","volume":"12","author":"Isley","year":"2011","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.jogc.2018.11.030_bib0034","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2174\/1874325001105010324","article-title":"Bone mineral density in healthy female adolescents according to age, bone age and pubertal breast stage","volume":"5","author":"de Oliveria","year":"2011","journal-title":"Open Orthop J"},{"key":"10.1016\/j.jogc.2018.11.030_bib0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jpag.2011.07.014","article-title":"Bone mineral density, fracture, and vitamin D in adolescents and young women using depot medroxyprogesterone acetate","volume":"25","author":"Pitts","year":"2012","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.jogc.2018.11.030_bib0036","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jpag.2004.01.006","article-title":"Weight gain, adiposity, and eating behaviors among adolescent females on depot medroxyprogesterone acetate (DMPA)","volume":"17","author":"Bonny","year":"2004","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.jogc.2018.11.030_bib0037","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/01.ogx.0000175805.90122.af","article-title":"Contraceptive and therapeutic effects of the levonorgestrel intrauterine system: an overview","volume":"60","author":"Jensen","year":"2005","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.jogc.2018.11.030_bib0038","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1471-0528.1990.tb16240.x","article-title":"Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia","volume":"97","author":"Andersson","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.jogc.2018.11.030_bib0039","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0010-7824(01)00302-X","article-title":"Bleeding patterns and clinical performance of the levonorgestrel- releasing intrauterine system (Mirena) up to two years","volume":"65","author":"Hidalgo","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2018.11.030_bib0040","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/AOG.0b013e3181ec622b","article-title":"Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: a randomized controlled trial","volume":"116","author":"Kaunitz","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2018.11.030_bib0041","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.contraception.2008.12.001","article-title":"A nationwide cohort study of the use of the levonorgestrel intrauterine device in New Zealand adolescents","volume":"79","author":"Paterson","year":"2009","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.jogc.2018.11.030_bib0042","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/j.jpag.2010.01.042","article-title":"The use of Mirena IUS in adolescents: a review of the RCH experience","volume":"23","author":"Savasi","year":"2010","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.jogc.2018.11.030_bib0043","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jpag.2006.05.005","article-title":"Revisiting the intrauterine contraceptive device in adolescents","volume":"19","author":"Toma","year":"2006","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.jogc.2018.11.030_bib0044","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1471-0528.2009.02372.x","article-title":"The levonorgestrel IUS (Mirena) for the treatment of menstrual problems in adolescents with medical disorders or physical or learning disabilities","volume":"117","author":"Pillai","year":"2010","journal-title":"BJOG"},{"key":"10.1016\/j.jogc.2018.11.030_bib0045","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jpag.2012.05.005","article-title":"Menstrual suppression with the levonorgestrel intrauterine system in girls with developmental delay","volume":"25","author":"Hillard","year":"2012","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.jogc.2018.11.030_bib0046","series-title":"Canadian Cancer Statistics 2011","year":"2011"},{"key":"10.1016\/j.jogc.2018.11.030_bib0047","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/cncr.22199","article-title":"Prevention of severe menorrhagia in oncology patients with treatment- induced thrombocytopenia by luteinizing hormone-releasing hormone agonist and depo-medroxyprogesterone acetate","volume":"107","author":"Meirow","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.jogc.2018.11.030_bib0048","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/ajh.2830420404","article-title":"Prevention of hypermenorrhea with leuprolide in premenopausal women undergoing bone marrow transplantation","volume":"42","author":"Ghalie","year":"1993","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jogc.2018.11.030_bib0049","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/sj.bmt.1701187","article-title":"Luteinizing hormone-releasing hormone analogue: leuprorelin acetate for the prevention of menstrual bleeding in premenopausal women undergoing stem cell transplantation","volume":"21","author":"Chiusolo","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jogc.2018.11.030_bib0050","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3109\/10428190109097723","article-title":"Prevention of menstruation with leuprorelin (GnRH agonist) in women undergoing myelosuppressive chemotherapy or radiochemotherapy for hematological malignancies: a pilot study","volume":"42","author":"Lhomme","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jogc.2018.11.030_bib0051","first-page":"537","article-title":"Inducing amenorrhea during bone marrow transplantation. A pilot study of leuprolide acetate","volume":"42","author":"Laufer","year":"1997","journal-title":"J Reprod Med"},{"key":"10.1016\/j.jogc.2018.11.030_bib0052","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejogrb.2007.03.012","article-title":"Prevention and treatment of uterine bleeding in hematologic malignancy","volume":"134","author":"Quaas","year":"2007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jogc.2018.11.030_bib0053","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1592\/phco.31.11.1092","article-title":"Management of menorrhagia associated with chemotherapy-induced thrombocytopenia in women with hematologic malignancy","volume":"31","author":"Bates","year":"2011","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jogc.2018.11.030_bib0054","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/pbc.23360","article-title":"The management of menstrual suppression and uterine bleeding: a survey of current practices in the Pediatric Blood and Marrow Transplant Consortium","volume":"59","author":"Adegite","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jogc.2018.11.030_bib0055","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/AOG.0b013e31827374e2","article-title":"Gonadatrophin suppression to prevent chemotherapy- induced ovarian damage: a randomized controlled trial","volume":"121","author":"Elgindy","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2018.11.030_bib0056","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1093\/annonc\/mdq066","article-title":"No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study Group","volume":"21","author":"Behringer","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jogc.2018.11.030_bib0057","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/sj.bmt.1704577","article-title":"Treatment of menorrhagia in women undergoing hematopoietic stem cell transplantation","volume":"34","author":"Amsterdam","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jogc.2018.11.030_bib0058","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/(SICI)1096-8652(199603)51:3<248::AID-AJH17>3.0.CO;2-C","article-title":"Treatment and prophylaxis of hypermenorrhea with leuprorelin in premenopausal women affected by acute leukemia at diagnosis","volume":"51","author":"Sica","year":"1996","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jogc.2018.11.030_bib0059","series-title":"Medical eligibility criteria for contraceptive use","year":"2009"},{"key":"10.1016\/j.jogc.2018.11.030_bib0060","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000206704","article-title":"Successful embolization for uterine hemorrhage in a patient with acute promyelocytic leukemia","volume":"70","author":"Katagiri","year":"1983","journal-title":"Acta Haematol"},{"key":"10.1016\/j.jogc.2018.11.030_bib0061","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/ajh.20113","article-title":"Near-fatal uterine hemorrhage during induction chemotherapy for acute myeloid leukemia: a case report of bilateral uterine artery embolization","volume":"77","author":"Phelan","year":"2004","journal-title":"Am J Hematol"}],"container-title":["Journal of Obstetrics and Gynaecology Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216318309952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216318309952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:33:02Z","timestamp":1761665582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1701216318309952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S1701216318309952"],"URL":"https:\/\/doi.org\/10.1016\/j.jogc.2018.11.030","relation":{},"ISSN":["1701-2163"],"issn-type":[{"value":"1701-2163","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"No. 313-Menstrual Suppression in Special Circumstances","name":"articletitle","label":"Article Title"},{"value":"Journal of Obstetrics and Gynaecology Canada","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogc.2018.11.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 The Society of Obstetricians and Gynaecologists of Canada\/La Soci\u00e9t\u00e9 des obst\u00e9triciens et gyn\u00e9cologues du Canada. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}